Platinum sensitive recurrence/suspected recurrence of ovarian cancer
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Selection criteria: 1) Non mucinous ovarian epithelial carcinoma; 2) Sensitive to platinum based chemotherapy drugs. 3) Pathological or clinical follow-up confirms/suspects recurrence of ovarian cancer. 4) Age>18 years old,<80 years old; 5) Volunteer to participate and cooperate throughout the entire process to complete 18F-FDG and 68Ga-FAPI PET/CT imaging; 6) Sign an informed consent form.
Exclusion criteria
Exclusion criteria: Exclusion criteria: 1) Previous malignant tumors in other areas; 2) Mucinous cystadenocarcinoma or non epithelial ovarian cancer; 3) Platinum resistance; 4) Pathological or clinical exclusion of recurrence; 5) Unable to lie flat for 15-30 minutes; 6) Refusal to participate in the clinical trial or unsigned consent form.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Gene mutation status (BRCA1/BRCA2/HRD/HRR);Tumor indicators before imaging (CA125/HE4); | — |
Primary
| Measure | Time frame |
|---|---|
| SUVmax; | — |
Countries
China
Contacts
the First Affiliated Hospital of the People's Liberation Army Air Force Military Medical University